Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Every Cure is a nonprofit organization dedicated to unlocking the full potential of every existing medicine to treat every disease possible.
Nura Health creates an all-inclusive precision medicine platform that speeds up endometriosis early detection and individualized care.
Steer Bio is a biotechnology company that specializes in revitalizing cell-based medicines.
Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
BioCurie is developing an artificial intelligence software platform to better cell and gene therapy.
SynthX Center is a biomedical research center focused on developing drugs and health technologies.
SecondWave Systems is an ultrasound stimulation platform.
Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.
Homeward is focused on improving access to high-quality, affordable primary and specialty care in rural communities.
Mission Mobile Medical provides mobile medical units at low costs.
Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.
34 Lives strives to reduce this statistic to zero by providing innovative technology and services for the kidney transplant process.
Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacement therapies.
Cision Vision is a developer and seller of imaging medical devices.
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.
Satio brings a dried blood spot and whole blood collection to the consumer; simple, painless, and clean using patches.
Medentum Innovations promotes health equity and transforming healthcare through affordable, high-performance point-of-care devices.
Advanced Research Projects Agency for Health has invested in 47 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Advanced Research Projects Agency for Health's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Health Diagnostics. The firm invests across 16 different industry categories.
Among tracked funding rounds, Every Cure received $60.0M in a Grant round. Advanced Research Projects Agency for Health's total known invested capital is $835.1M.
Advanced Research Projects Agency for Health's average investment size is $20.9M across its portfolio of 47 companies.
Recent Advanced Research Projects Agency for Health portfolio additions include Every Cure, Nura Health, Steer Bio, Transposon Therapeutics, Seaport Therapeutics. These companies were founded in 2020 or later.